Winter, 2008
Volume 6, Issue 1
 
Français arrow Home arrow PDF Version (4.3MB) arrow Past Issues arrow Contact us arrow
 
In This Issue

IMRIS:
Mobile magnet pulls award-
winning team to spotlightarrow


Company Profiles Ask a Patent Expertarrow
Market Report Highlightsarrow

Research Institute Profile Winter 2008 Eventsarrow
Useful Linksarrow
Year in Review 2007arrow

divider


Editor-in-Chief
  • Katherine Taverner
Publication Officer
  • Adam Levin
Editors
  • Roxanne Deslauriers
  • Don Douglas
  • Vera Keown
  • Graham North
  • Louis Renaud
  • Pauline Walsh
  • Joe Wery

bottom margin
  ISSN: 1712-3518
 

Year in Review 2007

 

February

Toronto-based Novadaq Technologies Inc.’s SPY Intra-operative Imaging System received a Japanese patent. Novadaq developed the SPY system, which monitors blood flow through grafts during cardiac procedures, in collaboration with the National Research Council.

Novadaq’s HELIOS system had just received FDA 510(k) approval in January. Plastic surgeons use the fluorescent HELIOS system to monitor blood flow in reconstructive plastic surgery.
divider

May

BIO 2007 in Boston, Massachusetts, USA, was the largest to date.
divider

June

BioTransfer 2007, a collaboration of McGill University and the National Research Council’s Biotechnology Research Institute, showcased two dozen new technologies for potential investors at NRC-BRI in Montreal.

The Health Care Products Association of Manitoba (HCPAM) votes to phase in a new name, Life Sciences Association of Manitoba (LSAM), with a new logo to match.
divider

October

The federal government announces $105 million in funding for seven Centres of Excellence, including three neurology-based institutes: the Brain Research Centre at the University of British Columbia; McGill University’s Montreal Neurological Institute; and the Life Sciences Research Institute in Halifax. The LSRI’s Brain Repair Centre is affiliated with Dalhousie University as well as both the NRC’s Institute for Biodiagnostics and the Industrial Research Assistance Program. The BRC has also received funding through the Canada Foundation for Innovation and through the Atlantic Canada Opportunities Agency’s Atlantic Innovations Fund.
divider

November

IMRIS Inc., an NRC spin-off, raised $40 million in their oversubscribed initial public offering (IPO) on the TSX. This is one of the largest Canadian medical device company IPOs in TSX/TSE history. See the profile of IMRIS in this issue.

The 14th annual BioNorth Biotechnology and Life Sciences Conference, focusing on commercializing Ontario biotech companies, was held November 19-20 in Ottawa.
divider


Copyright 2006 Medical Technology Watch Canada spacer National Research Council